Cornell Tech’s economic impact on NYC to double by 2030

A new analysis finds that Cornell Tech, its alumni and startups achieved $768 million in total economic impact in New York City in the 2023-24 fiscal year. That impact is expected to reach $1.5 billion by 2030.

Cornell Tech Alumni Close $3.2 Million Seed Round for Avina

It’s no secret that coordination between marketing and sales is an important component of generating revenue for businesses – unfortunately the reality isn’t quite so harmonious. Businesses invest countless hours and thousands of…

Around Cornell

Virtual screening IDs potential small molecule drugs for cancer immunotherapy

The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.

Student creates smart glasses for people with hearing loss

The glasses use AI to provide transcriptions of conversations in real time, which can be viewed both on the glasses and on a phone.

Grant to help develop portable PET scanner for Alzheimer’s

Weill Cornell Medicine researchers have received a five-year, $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution Positron Emission Tomography scanner that can detect the earliest stages of Alzheimer’s disease.

Disclose invisible disabilities in social VR? It depends

Cornell researchers have found that in social VR settings, the decision to disclose an invisible disability – a physical, mental or neurological condition that’s not apparent but can limit a person’s movements, senses or activities – is personal.

Grant will fund pain control research for critically ill children

Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.

Discovery reveals how ovarian cancer disables immune cells

Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.

A fully automated AI-based system can assess IVF embryo quality

A new system can accurately assess the chromosomal status of in vitro-fertilized embryos using only time-lapse video images of the embryos and maternal age, according to a study from investigators at Weill Cornell Medicine.